跳至主要内容
临床试验/NCT02272374
NCT02272374Unknown不适用

Vascular Access Choice and Outcomes in the Elderly and Very Elderly With End Stage Renal Disease in China :a Multicenter Prospective Cohort Study

Shanghai Changzheng Hospital1 个研究点 分布在 1 个国家目标入组 500 人开始时间: 2014年10月最近更新:
适应症

试验速览

阶段
不适用
入组人数
500
试验地点
1
主要终点
The patency rate of vascular access

研究概览

简要总结

The purpose of the study is to evaluate the clinical outcomes and cost-effectiveness of different vascular access(arteriovenous fistula, tunneled cuffed catheter and arteriovenous graft) in the elderly and very elderly with end-stage renal disease in China.

研究设计

研究类型
Interventional
分配方式
Non Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
65 Years 至 —(Older Adult)
性别
All
接受健康志愿者

入选标准

  • The elderly and very elderly with end stage renal disease.
  • Estimated glomerular filtration rate (eGFR) <20ml/min*1.73m2
  • All study subjects agree to participate in the study and provide written informed consent.

排除标准

  • Patients' life expectancy is less than 2 years.
  • Mental illness that makes the patients unable to complete the trial.

结局指标

主要结局

The patency rate of vascular access

时间窗: 2 years

Including primary and secondary patency rate.Blood flow can be above 500 mL/min in a mature arteriovenous fistula by ultrasound scan and 4 times of body weight (Kg\*4 mL/min) in a arteriovenous graft or tunneled cuffed catheter in dialysis practice.

Effect of vascular access construction on ventricular volumes and left ventricular remodeling

时间窗: 2 years

Assessed by doppler echocardiography

Effect of vascular access construction on brain MRI and cognitive functionslesions and cognitive function

时间窗: 2 years

Cognitive functions are assessed by psychic and autonomy scores

次要结局

  • Mortality due to vascular access(2 years)
  • Cost-effectiveness of different vascular access(2 years)
  • Complications of vascular access(2 years)
  • Hospitalization rate due to vascular access.(2 years)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Changlin Mei

Professor, Director, Division of Nephrology

Shanghai Changzheng Hospital

研究点 (1)

Loading locations...

相似试验